Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
Xiaofei Zhou, Ulka Vaishampayan, Devalingam Mahalingam, R. Donald Harvey, Ki Young Chung, Farhad Sedarati, Cassie Dong, Douglas V. Faller, Karthik Venkatakrishnan, Neeraj Gupta
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors'. Together they form a unique fingerprint.